MAGED2 Peptide

Product Discontinued

MAGED2 Peptide Summary

• Immunogen: This protein is not active and should not be used for experiments requiring activity.
• Protein/Peptide Type: Peptide
• Gene: MAGED2

Applications/Dilutions

• Dilutions:
  • Block/Neutralize
• Application Notes: This peptide is useful as a blocking peptide for PAB4757.
  This product may contain endotoxins and is not suitable for use with live cells.
  
  For further blocking peptide related protocol, click here.

Reactivity Notes

Human

Packaging, Storage & Formulations

• Storage: Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
• Buffer: Lyophilized with 100% acetonitrile. Reconstitute with 100 uL deionized water for a final concentration of 1 mg/mL.
• Preservative: No Preservative

Notes

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for MAGED2 Peptide

• 11B6MAGE-D2 antigen
• BCG-1
• BCG1MAGEDHCA10
• breast cancer associated gene 1
• Breast cancer-associated gene 1 protein
• hepatocellular carcinoma associated protein
• hepatocellular carcinoma-associated protein HCA10
• Hepatocellular carcinoma-associated protein JCL-1
• JCL-1
• MAGE-D2
• melanoma antigen family D, 2
• melanoma-associated antigen D2
• MGC8386

Background

MAGED2 was identified as a gene involved in X-linked mental retardation. MAGED2 is a member of the MAGED gene family whose members are clustered on chromosome Xp11.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: MAGED2